cilengitide has been researched along with Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritzenthaler, JD; Roman, J; Torres-Gonzalez, E; Zhang, M | 1 |
| Altavilla, D; Bagnato, G; Bagnato, GL; Bitto, A; Irrera, N; Pallio, G; Pizzino, G; Roberts, WN; Saitta, A; Santoro, D; Squadrito, F; Vaccaro, M | 1 |
2 other study(ies) available for cilengitide and Pulmonary Fibrosis
| Article | Year |
|---|---|
The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.
Topics: Animals; Bleomycin; Cell Adhesion; Cell Culture Techniques; Cell Survival; Disease Models, Animal; Fibroblasts; Male; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pulmonary Fibrosis; Snake Venoms | 2020 |
Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.
Topics: Animals; Arteries; Disease Models, Animal; Female; Fibrosis; Gene Expression; Humans; Integrin alphaVbeta3; Mice, Inbred BALB C; Pulmonary Fibrosis; Receptors, Vitronectin; Scleroderma, Systemic; Skin; Snake Venoms; Transforming Growth Factor beta1 | 2018 |